Global Intrathecal Pumps Market Report and Forecast 2024-2032

Global Intrathecal Pumps Market Outlook

The global intrathecal pumps market size attained a value of about USD 301.92 million in 2023. The market is likely to grow further at a CAGR of 5.2% during the forecast period of 2024-2032, likely to attain a value of about USD 476.47 million by 2032. The growth of the market is expected to be aided by the rapid technological advancements in the market.

Key Trends in the Market

Intrathecal pumps, commonly known as pain pumps, are a small pump used for the delivery of small doses of pain medication directly into the spinal cord. The battery used in the intrathecal pump can last for anywhere between 4 years and 7 years and alerts the user upon expiry. The pumps are implanted in the patients and can be removed only surgically.

• Advancements in technologies such as improvement in pump delivery modes, as well as safety and longer battery life, and specialised features in these devices are key trends in the market. 

• The development of Prometra II programmable pump for treating spasticity and similar conditions is a major key trend of the global market for intrathecal pumps. It has 10 years of battery life and uses a pressure-driven system which will reduce the need for surgery. 

• Intrathecal pumps are widely used by cancer patients and by people with other pain disorders. Using them reduces the pain and reduces the risk of addiction to opioids which is ultimately helping in the growth of the global intrathecal pumps market. 

• With the increase in chronic pain conditions as a result of sedentary lifestyles and added stress, pain management is a priority for many patients worldwide. Intrathecal pumps are an effective means of helping people suffering from chronic pain in leading normal lives. 

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis

Based on type, the intrathecal pumps market can be segmented into baclofen, bupivacaine, morphine, hydromorphone, and others. On the basis of application, it can be bifurcated into spasticity and pain. By end use, the market is divided into hospitals and clinics, and ambulatory surgery centres. The regional markets can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa.  

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global intrathecal pumps market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.  

• Tricumed Medizintechnik GmbH

• Medtronic Plc

• Flowonix Medical Inc

• Zimmer Biomet Holdings, Inc.

• Johnson and Johnson Services, Inc. 

• DURECT Corporation

• Others

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Share by Type

Morphine has the largest share in the global intrathecal pumps market because it is a strong receptor and is stable. The United States FDA has also approved morphine to be used for long term pain treatment through intrathecal pumps. Bupivacaine is known to improve the effect of opioids when used through intrathecal pumps and is expected to increase the growth of the market. Baclofen usage in the treatment of spasticity and different kind of pains is also contributing to the growth of the market. 

Market Share by Application

The pain segment is leading the market due to the increase in prevalence of chronic disorders and pain causing ailments such as cancer, nerve conditions, and spinal issues, and failed back surgery syndrome. Various players are focusing on the development of spasticity treatment products due to rising cases of strokes which will also help in the overall growth of the global intrathecal pumps market. 

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

Tricumed Medizintechnik GmbH has its headquarter in Keil, Germany, and is a medical device company. It has been developing innovative technologies such as infusion pumps, intrathecal pumps, and others for more than 20 years now. 

Medtronic Plc was established in 1949 and has its headquarter in Dublin, Ireland. A medical device company which develops therapeutic medical devices, it also uses biomedical engineering to research and design improved products for improved health results. 

Flowonix Medical Inc. was founded in 2005 and has its headquarter in New Jersey, United States. It is a medical device company focused on providing optimal solutions to the medical industry for treatment of neurological disorders. 

Other market players include Zimmer Biomet Holdings, Inc., Johnson and Johnson Services, Inc., and Durect Corporation, among others. 

Key Highlights of the Report